相关实验视频
Updated: Jun 28, 2025

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
407
在人类瘤中ESCO2的致癌作用:泛癌分析和实验验证
Yue Huang1, Dapeng Chen2, Yi Bai3
1Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
BMC cancer
|April 11, 2024
概括
姐妹染色体凝聚力N-乙转移酶2 (ESCO2) 在大多数癌症中经常被上调,作为潜在的瘤基因和泛癌症生物标志物. 它的抑制会影响癌细胞的增殖和入侵,这表明ESCO2是治疗点.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 姐妹染色体凝聚力N-乙转移酶2 (ESCO2) 对于线粒体S相乙化和染色体桥接至关重要.
- 目前对癌症中的ESCO2的研究是有限的,缺乏全面的泛癌分析.
研究的目的:
- 对ESCO2在癌症诊断,预后和效应器功能中的作用进行系统的泛癌症分析.
- 研究ESCO2作为泛癌生物标志物和治疗点的潜力.
主要方法:
- 利用公共数据库 (TCGA,GTEx,UALCAN,TISCH) 进行差异表达,生存,突变和单细胞分析.
- 评估ESCO2对细胞功能的影响,免疫细胞透,以及ccRCC细胞的体外增殖/侵入.
主要成果:
- 在33种癌症类型中,ESCO2在30种癌症中过度表达,在急性髓性白血病中表达较低.
- 高ESCO2表达与几种癌症的预后不佳相关,但在其他癌症中有利 (THYM,COAD,READ).
- ESCO2 影响细胞循环,DNA 修复,线粒分裂和免疫透;它的敲击抑制了癌细胞的增殖和入侵.
结论:
- 作为潜在的泛癌生物标志物和瘤基因,ESCO2可预测患者的预后.
- 埃斯科2在细胞循环和增殖调节中的作用突显了其治疗可行性.
- 在癌症治疗中,ESCO2 是一个可靠且在治疗上可行的目标.
相关概念视频
Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K

